Vancomycin hydrochloride and Foscavir drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Vancomycin hydrochloride (vancomycin hydrochloride) and Foscavir (foscarnet sodium). Common drug interactions include liver disorder among females and respiratory failure among males.

The phase IV clinical study analyzes what interactions people have when they take Vancomycin hydrochloride and Foscavir. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.

What is Vancomycin hydrochloride?

Vancomycin hydrochloride has active ingredients of vancomycin hydrochloride. It is often used in mrsa infection. eHealthMe is studying from 8,399 Vancomycin hydrochloride users. Check the latest studies of Vancomycin hydrochloride.

What is Foscavir?

Foscavir has active ingredients of foscarnet sodium. eHealthMe is studying from 1,631 Foscavir users. Check the latest studies of Foscavir.

On Jul, 18, 2026

29 people who take Vancomycin hydrochloride and Foscavir together, and have interactions are studied.

Vancomycin hydrochloride and Foscavir drug interactions.

What are the common drug interactions of Vancomycin Hydrochloride and Foscavir, by gender? *:

female:

Liver disorder (liver diseases)
Septic shock (shock due to blood infection)
Angioimmunoblastic t-cell lymphoma (mature t-cell cancer of the blood or lymph vessel)
Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
Enterococcal bacteraemia (presence of bacteria lactic acid in the blood)
Pancreatitis acute (sudden inflammation of pancreas)
Posterior reversible encephalopathy syndrome (posterior reversible encephalopathy syndrome (pres), also known as reversible posterior leukoencephalopathy syndrome (rpls), is a syndrome characterized by headache, confusion, seizures and visual loss)
Systemic candida (whole body fungal infection)
Cytomegalovirus infection
Epstein-barr virus infection

male:

Respiratory failure (inadequate gas exchange by the respiratory system)
Renal impairment (severely reduced kidney function)
Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
Pneumonia
Renal failure (kidney dysfunction)
Venoocclusive liver disease (small veins in the liver are obstructed)
Alanine aminotransferase increased
Blood alkaline phosphatase increased
Blood potassium increased

What are the common drug interactions of Vancomycin Hydrochloride and Foscavir, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Anaemia (lack of blood)
Myelodysplastic syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged)
Neutropenia (an abnormally low number of neutrophils)
Pulmonary haemorrhage (acute bleeding from the lung)
Renal failure (kidney dysfunction)
Thrombocytopenia (decrease of platelets in blood)
Thrombotic microangiopathy (a pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury)

10-19:

Abdominal pain
Acute lymphocytic leukaemia (cancer of the white blood cells)
Arthralgia (joint pain)
Bacterial infection
Blood creatinine increased
Cough
Cytomegalovirus infection
Diarrhoea
Epistaxis (bleed from the nose)
Epstein-barr virus infection

20-29:

Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
Respiratory failure (inadequate gas exchange by the respiratory system)
Venoocclusive liver disease (small veins in the liver are obstructed)
Blood alkaline phosphatase increased
Blood bilirubin increased
Cell death
Gamma-glutamyltransferase increased
Thrombotic microangiopathy (a pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury)

30-39:

n/a

40-49:

Graft versus host disease in intestine (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body and damages intestinal mucosal membrane)
Hepatitis fulminant (life-threatening condition defined by significantly impaired liver function)
Multi-organ failure (multisystem organ failure)
Renal failure acute (rapid kidney dysfunction)
Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
Bladder disorder
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
Haematuria (presence of blood in urine)
Oedema (fluid collection in tissue)
Skin exfoliation (removal of the oldest dead skin cells)

50-59:

Blood bilirubin increased
Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
Pneumonia
Renal failure (kidney dysfunction)
Respiratory failure (inadequate gas exchange by the respiratory system)
Alanine aminotransferase increased
Blood potassium increased
Haematocrit decreased
Haemoglobin decreased
Platelet count decreased

60+:

Renal impairment (severely reduced kidney function)
Liver disorder (liver diseases)
Depressed level of consciousness
Engraftment syndrome (inflammatory condition during neutrophil recovery after hematopoietic stem cell transplantation)
Fibrin degradation products increased
Hyperglycaemia (high blood sugar)
Pleural effusion (water on the lungs)
Weight increased
Cerebral haemorrhage (bleeding within the brain)
Histiocytosis haematophagic

What are the existing conditions these people have? *

Infection: 7 people, 24.14%
Cytomegalovirus Infection: 6 people, 20.69%
Bone Marrow Conditioning Regimen: 5 people, 17.24%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 4 people, 13.79%
Angioimmunoblastic T-Cell Lymphoma (mature t-cell cancer of the blood or lymph vessel): 3 people, 10.34%
Adverse Event: 3 people, 10.34%
Bronchopulmonary Aspergillosis (lung disorder caused by aspergillus fungi): 3 people, 10.34%
Septic Shock (shock due to blood infection): 3 people, 10.34%
Immunodeficiency Disorders: 3 people, 10.34%
Enterococcal Infection: 3 people, 10.34%

* Approximation only. Some reports may have incomplete information.

Do you take Vancomycin hydrochloride and Foscavir?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously